CVE-2018-18630
A vulnerability was found in McKesson Cardiology product 13.x and 14.x.
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (0.33%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
A vulnerability was found in McKesson Cardiology product 13.x and 14.x. Insecure file permissions in the default installation may allow an attacker with local system access to execute unauthorized arbitrary code.
- CVSS 3.1
- 7.8 HIGHCVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
- EPSS
- 0.33% probability · 26th percentile
- Public exploits
- None in Exploit-DB
- CISA KEV
- Not listed
- Weakness
- CWE-732
- Affected
- mckesson/horizon cardiology firmware · mckesson/cardiology firmware · changehealthcare/cardiology firmware
- Source
- cve@mitre.org
EPSS 0.3% since 27 October 2026; no change recorded yet. Points are recorded when the score first appears and whenever it moves by a percentage point or more.
References
- https://www.hipaajournal.com/code-execution-vulnerability-identified-in-change-healthcare-cardiology-devices/Third Party Advisory
- https://www.us-cert.gov/ics/advisories/icsma-19-241-01Third Party Advisory, US Government Resource
- https://www.hipaajournal.com/code-execution-vulnerability-identified-in-change-healthcare-cardiology-devices/Third Party Advisory
- https://www.us-cert.gov/ics/advisories/icsma-19-241-01Third Party Advisory, US Government Resource
Source: NVD record, EPSS from FIRST.org, KEV from CISA, exploits from Exploit-DB. Refreshed daily. Download this record as JSON.